Description: Cytokeratin-18-based apoptosis and necrosis CE-marked biomarker assays M30 Apoptosense and M65 ELISA for in vitro diagnostic for clinical NASH, NAFLD diagnostics in hepatology and drug development in cancer research
m30 (9) m65 (9) cytokeratin-18 (1) keratin 18 (1) apoptosis. (1)
Combining M30 Apoptosense® with FIB-4 laboratory assessment of hepatic fibrosis in NAFLD
View the diagnostic decision tree >
PEVIVA Product Application Guide